Edition:
United States

MYOS RENS Technology Inc (MYOS.OQ)

MYOS.OQ on NASDAQ Stock Exchange Capital Market

1.22USD
4:00pm EDT
Change (% chg)

$0.02 (+1.67%)
Prev Close
$1.20
Open
$1.20
Day's High
$1.22
Day's Low
$1.20
Volume
5,375
Avg. Vol
28,748
52-wk High
$2.50
52-wk Low
$1.05

Chart for

About

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle... (more)
No analyst recommendations are available for .

Overall

Beta: 0.27
Market Cap(Mil.): $7.89
Shares Outstanding(Mil.): 5.84
Dividend: --
Yield (%): --

Financials

  MYOS.OQ Industry Sector
P/E (TTM): -- 22.36 40.74
EPS (TTM): -0.71 -- --
ROI: -67.54 12.28 62.35
ROE: -68.27 15.68 73.96

BRIEF-Myos Rens Technology Reports Qtrly Loss Per Share $0.19

* MYOS RENS TECHNOLOGY REPORTS FIRST QUARTER FINANCIAL RESULTS

May 09 2018

BRIEF-Joseph Mannello Reports 9.3 Pct Stake In Myos Rens Technology Inc

* JOSEPH MANNELLO REPORTS 9.3 PERCENT STAKE IN MYOS RENS TECHNOLOGY INC AS OF APRIL 27, 2018 - SEC FILING Source text: (https://bit.ly/2FTnvnk) Further company coverage:

May 07 2018

BRIEF-David Matlin Reports 8.29 Pct Passive Stake In MYOS RENS Technology As Of April 25, 2018

* DAVID J. MATLIN REPORTS 8.29 PERCENT PASSIVE STAKE IN MYOS RENS TECHNOLOGY AS OF APRIL 25, 2018 - SEC FILING Source text : (https://bit.ly/2rgSl4d) Further company coverage:

May 02 2018

Competitors

Earnings vs. Estimates